Skip to main content
Svas Biosana logo

Svas Biosana — Investor Relations & Filings

Ticker · SVS ISIN · IT0005469264 LEI · 81560055A88E1D16D537 XMIL Manufacturing
Open in API
Filings indexed 284 across all filing types
Latest filing 2023-07-14 Transaction in Own Shar…
Country IT Italy
Listing XMIL SVS

About Svas Biosana

https://svas.it/en/

Svas Biosana is a company that specializes in the planning, manufacturing, and distribution of medical devices and pharmaceutical products. The company's portfolio includes a range of disposable hospital supplies, such as incontinence aids and traditional dressings. Serving both public and private health institutions, Svas Biosana develops, produces, and distributes its own branded products as well as those from third-party manufacturers.

Recent filings

Filing Released Lang Actions
Acquisto azioni proprie
Transaction in Own Shares Classification · 98% confidence The document is titled 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Information on Own Share Purchase) and the 'Oggetto' (Subject) is 'Acquisto azioni proprie' (Purchase of own shares). It details the number of shares repurchased during a specific weekly period (July 10 to July 14, 2023) and the total holding of treasury shares. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category (POS). Although it is a formal communication ('Informazione Regolamentata'), the specific content dictates the POS classification over a general regulatory filing (RNS).
2023-07-14 Italian
Emissione Prestiti Obbligazionari
Capital/Financing Update Classification · 99% confidence The document is titled 'COMUNICATO STAMPA' (Press Release) and its subject ('Oggetto') is 'Emissione Prestiti Obbligazionari' (Issuance of Bonds). The text details the completion of issuing two corporate bonds totaling Euro 13 million to support the Group's investment plan. This clearly relates to corporate financing activities, specifically debt issuance. This aligns directly with the definition for Capital/Financing Update (CAP). Although it is a press release, the core content is the financing event itself, not just an announcement of a report's publication (RPA/RNS). The length (11,220 chars) suggests it is the substantive announcement, not just a brief notice.
2023-07-13 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 99% confidence The document is titled 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Information on Own Share Purchase) and details the number of shares repurchased by Svas Biosana S.p.A. between July 3 and July 7, 2023. The subject line explicitly states 'Acquisto azioni proprie' (Purchase of own shares). This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps precisely to the 'Transaction in Own Shares' category. Filing Type Code: POS (Transaction in Own Shares).
2023-07-07 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and details the number of shares repurchased by Svas Biosana S.p.A. between June 26, 2023, and June 30, 2023. The subject line explicitly states "Acquisto azioni proprie" (Purchase of own shares). This activity falls directly under the definition of a company buying back or selling its own shares, which corresponds to the 'Transaction in Own Shares' category (POS). Although it is a formal communication, the specific nature of the content overrides the general 'RPA' or 'RNS' fallback.
2023-06-30 Italian
Avvio 2° periodo Warrant Svas Biosana 2021-2024
Notice of Dividend Amount Classification · 99% confidence The document is an official communication from Svas Biosana S.p.A. filed under 'Informazione Regolamentata' (Regulated Information) on Euronext Growth Milan. The subject is the 'Avvio 2° periodo Warrant Svas Biosana' (Start of the 2nd exercise period for Svas Biosana Warrants). This announcement details the terms, dates (July 3 to July 31, 2023), and price for exercising warrants to subscribe to new shares. This type of announcement, concerning the terms of capital instruments (warrants) and their exercise, falls under financing activities or capital structure changes. The most appropriate category among the provided options is 'Capital/Financing Update' (CAP). It is not a full report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS), as it pertains specifically to a financing mechanism.
2023-06-29 Italian
Emissione prestiti obbligazionari
Capital/Financing Update Classification · 98% confidence The document is an official communication ('Informazione Regolamentata') from Svas Biosana S.p.A. The subject ('Oggetto') is 'Emissione prestiti obbligazionari' (Issuance of bond loans). The text details the resolution by the Board of Directors to issue two non-convertible bond loans totaling Euro 13 million to support growth and investments. This clearly relates to fundraising, financing activities, and capital structure changes. This aligns perfectly with the definition for Capital/Financing Update (CAP). Although it mentions 'Vedi allegato' (See attachment), the core content is the announcement of the financing decision itself, not just a placeholder for a report, making CAP more specific than RPA or RNS.
2023-06-28 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.